A petition has been submitted to the People's Majlis calling for expanded healthcare coverage and financial support for individuals with Type 1 diabetes under the national health insurance scheme, Aasandha.

The proposal was put forward by Galolhu North MP Mohamed Ibrahim, who expressed concerns about the high costs of treatment and limited access to essential medical supplies for managing the condition.

Type 1 diabetes is an autoimmune disorder where the immune system attacks insulin-producing cells in the body. It can develop at any age and requires lifelong management through insulin injections, blood glucose monitoring, and regular medical care.

In a letter to Parliament, Mohamed Ibrahim requested the Social Affairs Committee to invite senior officials from Aasandha to discuss potential measures to address the challenges faced by patients and their families.

The proposed measures include:

- Providing blood glucose meters and test strips for all diagnosed individuals, including those over 25, under Aasandha.

- Extending full coverage for Continuous Glucose Monitor (CGM) sensors.

- Establishing a system to import and distribute insulin pumps and related supplies within the Maldives.

- Ensuring a consistent supply of insulin nationwide.

- Improving access to MM4-sized needles used by children.

- Facilitating quicker access to specialist consultations at government hospitals or enabling coverage for private clinic visits under Aasandha.

- Offering financial aid for travel and accommodation costs for children traveling from atolls to Malé for treatment.

According to the Diabetes Society of Maldives (DSM), over 330 people are currently registered as living with Type 1 diabetes in the country. This includes 36 children under 10, 77 children under 18, and 110 adults over 18.

Insulin remains the primary treatment, with many patients administering it multiple times daily via injection pens to regulate blood sugar levels. Some patients use insulin pumps, which deliver insulin continuously through a device attached to the body. The parliamentary submission noted that around 16 children in the Maldives depend on insulin pumps.

The letter also raised concerns about accessing pump-related services and supplies, especially after the previous company importing insulin pumps into the Maldives ceased operations.

Mohamed Ibrahim stated that these proposed measures aim to lower treatment costs, improve healthcare access, and ensure patients receive the necessary supplies to manage their condition effectively.